BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32292674)

  • 1. An Atypical Cardiac Manifestation of Fabry Disease from a Novel Pathological Variant on the GLA Gene.
    Sarsam L; Arouni A; Mahfood Haddad T; Onaiwu CO; Erickson C
    Cureus; 2020 Mar; 12(3):e7262. PubMed ID: 32292674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and Screening of Patients with Fabry Disease.
    Vardarli I; Rischpler C; Herrmann K; Weidemann F
    Ther Clin Risk Manag; 2020; 16():551-558. PubMed ID: 32606714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anderson-Fabry disease: a multiorgan disease.
    Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
    Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabry disease and its cardiac involvement.
    Kubo T
    J Gen Fam Med; 2017 Oct; 18(5):225-229. PubMed ID: 29264031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance.
    Smid BE; van der Tol L; Cecchi F; Elliott PM; Hughes DA; Linthorst GE; Timmermans J; Weidemann F; West ML; Biegstraaten M; Lekanne Deprez RH; Florquin S; Postema PG; Tomberli B; van der Wal AC; van den Bergh Weerman MA; Hollak CE
    Int J Cardiol; 2014 Dec; 177(2):400-8. PubMed ID: 25442977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2021 TSOC Expert Consensus on the Clinical Features, Diagnosis, and Clinical Management of Cardiac Manifestations of Fabry Disease.
    Hung CL; Wu YW; Lin CC; Lai CH; Jyh-Ming Juang J; Chao TH; Kuo L; Sung KT; Wang CY; Wang CL; Chu CY; Yu WC; Hou CJ
    Acta Cardiol Sin; 2021 Jul; 37(4):337-354. PubMed ID: 34257484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabry disease: Definition, Incidence, Clinical presentations and Treatment
    Saeed S; Imazio M
    Pak J Med Sci; 2022; 38(8):2337-2344. PubMed ID: 36415271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare Etiology of Renal Failure in a 25-Year-Old Caucasian Man: Fabry Disease With a Novel Mutation of GLA Gene.
    Gaballa S; AlJaf A; Lindsay J; Patel K; Hlaing KM
    Cureus; 2020 Jul; 12(7):e9136. PubMed ID: 32699723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel double
    Hirose M; Okada S; Kobayashi Y
    Mol Genet Metab Rep; 2023 Sep; 36():100982. PubMed ID: 37332487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Difficulties in Diagnosing Fabry Disease in Patients with Unexplained Left Ventricular Hypertrophy (LVH): Is the Novel GLA Gene Mutation a Pathogenic Mutation or Polymorphism?
    Aladağ N; Ali Barman H; Şipal A; Akbulut T; Özdemir M; Ceylaner S
    Balkan J Med Genet; 2023 Jul; 26(1):43-50. PubMed ID: 37576794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Lyso-Gb3 Suggests the R118C GLA Mutation Is a Pathological Fabry Variant.
    Talbot A; Nicholls K
    JIMD Rep; 2019; 45():95-98. PubMed ID: 30569317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Fabry Disease in patients with left ventricular hypertrophy in Turkey: Multicenter study (LVH-TR subgroup analysis).
    Güzel T; Çağlar FNT; Ekici B; Kış M; Öztaş S; Öz A; Gök G; Kolak Z; Akşit E; Sarıca SA; Bayrak M; Birdal O; Uğuz B; Gitmez M; Berk Gİ; Oğuz M; Çalık AN; Kılıç S; Zoghi M; Ergene AO
    Int J Cardiovasc Imaging; 2023 Jun; 39(6):1143-1155. PubMed ID: 36920623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey.
    Barman HA; Özcan S; Atıcı A; Özgökçe C; Öztürk A; Kafalı AE; Çakar NE; Tavşanlı ME; Küçük M; Şahin I; Okuyan E
    Anatol J Cardiol; 2020 Jan; 23(2):79-85. PubMed ID: 32011328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young.
    De Brabander I; Yperzeele L; Ceuterick-De Groote C; Brouns R; Baker R; Belachew S; Delbecq J; De Keulenaer G; Dethy S; Eyskens F; Fumal A; Hemelsoet D; Hughes D; Jeangette S; Nuytten D; Redondo P; Sadzot B; Sindic C; Sheorajpanday R; Thijs V; Van Broeckhoven C; De Deyn PP
    Clin Neurol Neurosurg; 2013 Jul; 115(7):1088-93. PubMed ID: 23219219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal variant of Fabry disease with sporadic GLA gene mutation: role of early renal biopsy.
    Al-Salam S; Chaaban A; Al-Jasmi F; Amann K; Abouchacra S
    Clin Kidney J; 2012 Oct; 5(5):416-9. PubMed ID: 26019818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anderson-Fabry disease in heart failure.
    Akhtar MM; Elliott PM
    Biophys Rev; 2018 Aug; 10(4):1107-1119. PubMed ID: 29909504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the GLA gene in Mexican families with Fabry disease.
    Gutiérrez-Amavizca BE; Gal A; Ortíz-Orozco R; Orth U; Prado Montes De Oca E; Gutiérrez-Amavizca JP; Figuera LE
    J Genet; 2017 Mar; 96(1):161-164. PubMed ID: 28360401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabry disease: A fundamental genetic modifier of cardiac function.
    Tadevosyan A
    Curr Res Transl Med; 2017; 65(1):10-14. PubMed ID: 28340691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabry disease in South and Central Asia: Is it truly a rare disease or underappreciated?
    Saeed S; Imazio M
    Pak J Med Sci; 2022; 38(8):2373-2375. PubMed ID: 36415240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
    Chaves-Markman ÂV; Markman M; Calado EB; Pires RF; Santos-Veloso MAO; Pereira CMF; Lordsleem ABMDS; Lima SG; Markman Filho B; Oliveira DC
    Arq Bras Cardiol; 2019 Jul; 113(1):77-84. PubMed ID: 31291414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.